These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Chemical and pharmacological research on pyran derivatives. XV. Phenyl-substituted 2-(dialkylamino)chromones]. Balbi A; Roma G; Ermili A; Ambrosini A; Passerini N Farmaco Sci; 1982 Sep; 37(9):582-96. PubMed ID: 7128815 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents. Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380 [TBL] [Abstract][Full Text] [Related]
24. Synthesis, identification and antiplatelet evaluation of 2-morpholino substituted benzoxazines. Pritchard KM; Al-Rawi J; Bradley C Eur J Med Chem; 2007 Sep; 42(9):1200-10. PubMed ID: 17336427 [TBL] [Abstract][Full Text] [Related]
25. Cyclic guanidines: synthesis and antiplatelet activity of 4,6,7,8-tetrahydro-1H-imidazo[1,2-a]pyrazolo[3,4-d]pyrimidin-7-ones and 1,4,6,7,8,9-hexahydropyrazolo [3',4':4,5]pyrimido[2,1-c] [1,2,4]triazin-7-ones. Ferroni R; Simoni D; Orlandini P; Bardi A; Franze GP; Guarneri M Arzneimittelforschung; 1990 Dec; 40(12):1328-31. PubMed ID: 2095128 [TBL] [Abstract][Full Text] [Related]
26. New 2-amino-thiazole-4-acetamides with antiplatelet activity. Rehse K; Baselt T Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones. Di Braccio M; Grossi G; Signorello MG; Leoncini G; Cichero E; Fossa P; Alfei S; Damonte G Eur J Med Chem; 2013 Apr; 62():564-78. PubMed ID: 23425969 [TBL] [Abstract][Full Text] [Related]
28. New chiral inhibitors of induced platelet aggregation: the enantiomeric specificity of (R)- and (S)-methyl and ethyl esters of 1-(4-[(1-hydroxycarbonyl)-ethoxy]-benzyl)-1H-1,2,3-triazole as a tool for determining their biological target. Biagi G; Giorgi I; Livi O; Scartoni V; Catalani R; Gervasi G Farmaco; 1996 Dec; 51(12):761-6. PubMed ID: 9050207 [TBL] [Abstract][Full Text] [Related]
29. Synthesis, antiplatelet and vasorelaxing activities of xanthone derivatives. Lin KW; Fang SC; Hung CF; Shieh BJ; Yang SC; Teng CM; Lin CN Arch Pharm (Weinheim); 2009 Jan; 342(1):19-26. PubMed ID: 19035386 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors. Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and antiplatelet activity of new imidazole-4-carboxylic acid derivatives. Rehse K; Steege J Arch Pharm (Weinheim); 2005 Nov; 338(11):539-47. PubMed ID: 16281307 [TBL] [Abstract][Full Text] [Related]
32. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents. Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180 [TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of anti-thrombotic activity of benzocoumarin amide derivatives. Sashidhara KV; Palnati GR; Avula SR; Singh S; Jain M; Dikshit M Bioorg Med Chem Lett; 2012 May; 22(9):3115-21. PubMed ID: 22483393 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and anti-platelet activity of obovatol derivatives. Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and inhibitory effects of 1,2,4-triazole derivatives on platelet aggregation. Lagorce JF; Moulard T; Raby C Arzneimittelforschung; 1992 Mar; 42(3):314-8. PubMed ID: 1497691 [TBL] [Abstract][Full Text] [Related]
36. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones]. Jiang Q; Sun CS Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Wang WY; Hsieh PW; Wu YC; Wu CC Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492 [TBL] [Abstract][Full Text] [Related]
38. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives. Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783 [TBL] [Abstract][Full Text] [Related]
39. Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluation. Campillo N; García C; Goya P; Páez JA; Carrasco E; Grau M J Med Chem; 1999 May; 42(10):1698-704. PubMed ID: 10346922 [TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids. Vilar S; Quezada E; Santana L; Uriarte E; Yánez M; Fraiz N; Alcaide C; Cano E; Orallo F Bioorg Med Chem Lett; 2006 Jan; 16(2):257-61. PubMed ID: 16275073 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]